4.7 Article

Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Haptic-Assisted Interactive Molecular Docking Incorporating Receptor Flexibility

Nick Matthews et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Cell Biology

Cryo-EM structure of human mTOR complex 2

Xizi Chen et al.

CELL RESEARCH (2018)

Article Chemistry, Medicinal

Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR

Tao Yu et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation

Tong Han et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Medicine, Research & Experimental

Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a) pyrene-induced experimental lung carcinogenesis

Eshvendar Reddy Kasala et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Chemistry, Medicinal

Design, synthesis and anti-HIV activity of novel quinoxaline derivatives

Saloni B. Patel et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Engineering, Chemical

3D-QSAR studies on 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide derivatives as HIV-1 integrase inhibitors

Saloni Patel et al.

JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS (2016)

Article Chemistry, Organic

Design, synthesis and anticancer activities of novel otobain derivatives

Zhongzhou Li et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2016)

Review Oncology

Molecular histology of lung cancer: From targets to treatments

Steven L. Wood et al.

CANCER TREATMENT REVIEWS (2015)

Article Biochemistry & Molecular Biology

Antiproliferative and antioxidant potential of hesperetin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice

Lakshmi Narendra Bodduluru et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2015)

Article Chemistry, Medicinal

Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223

Deborah S. Mortensen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Cell Biology

mTORC2 controls cancer cell survival by modulating gluconeogenesis

M. W. Khan et al.

CELL DEATH DISCOVERY (2015)

Article Pharmacology & Pharmacy

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

Claudia Fumarola et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Pharmacology & Pharmacy

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

Jiri Polivka et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Article Multidisciplinary Sciences

mTOR kinase structure, mechanism and regulation

Haijuan Yang et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

Ramaswamy Govindan et al.

Article Medicine, General & Internal

Non-small cell lung cancer in never smokers: a clinical entity to be identified

Ilka Lopes Santoro et al.

CLINICS (2011)

Review Pharmacology & Pharmacy

Targeting the mTOR kinase domain: the second generation of mTOR inhibitors

Yan-Jie Zhang et al.

DRUG DISCOVERY TODAY (2011)

Article Chemistry, Organic

Synthesis of 6-Nitro-1,2,3,4-tetrahydroquinoline: An Experimental and Theoretical Study of Regioselective Nitration

Alessandra Cordeiro et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2011)

Article Chemistry, Medicinal

Synthesis and Significant Cytostatic Activity of 7-Hetaryl-7-deazaadenosines

Aurelie Bourderioux et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Diverse somatic mutation patterns and pathway alterations in human cancers

Zhengyan Kan et al.

NATURE (2010)

Article Medical Laboratory Technology

Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice

K Selvendiran et al.

CLINICA CHIMICA ACTA (2004)